GLUE
Price
$14.14
Change
+$0.36 (+2.61%)
Updated
Nov 19 closing price
Capitalization
920.77M
112 days until earnings call
Intraday BUY SELL Signals
PLUR
Price
$3.56
Change
-$0.08 (-2.19%)
Updated
Nov 19, 04:46 PM (EDT)
Capitalization
32.99M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs PLUR

Header iconGLUE vs PLUR Comparison
Open Charts GLUE vs PLURBanner chart's image
Monte Rosa Therapeutics
Price$14.14
Change+$0.36 (+2.61%)
Volume$524.65K
Capitalization920.77M
Pluri
Price$3.56
Change-$0.08 (-2.19%)
Volume$100
Capitalization32.99M
GLUE vs PLUR Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
PLUR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. PLUR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and PLUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (GLUE: $14.14 vs. PLUR: $3.57)
Brand notoriety: GLUE and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 29% vs. PLUR: 91%
Market capitalization -- GLUE: $920.77M vs. PLUR: $32.99M
GLUE [@Biotechnology] is valued at $920.77M. PLUR’s [@Biotechnology] market capitalization is $32.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • PLUR’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 2 TA indicator(s) are bullish while PLUR’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 2 bullish, 5 bearish.
  • PLUR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PLUR is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а -0.14% price change this week, while PLUR (@Biotechnology) price change was -19.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($921M) has a higher market cap than PLUR($33M). GLUE YTD gains are higher at: 103.746 vs. PLUR (-16.608). GLUE has higher annual earnings (EBITDA): 23.3M vs. PLUR (-20.22M). GLUE has more cash in the bank: 291M vs. PLUR (26.3M). PLUR has less debt than GLUE: PLUR (31.2M) vs GLUE (41.1M). GLUE has higher revenues than PLUR: GLUE (178M) vs PLUR (1.03M).
GLUEPLURGLUE / PLUR
Capitalization921M33M2,791%
EBITDA23.3M-20.22M-115%
Gain YTD103.746-16.608-625%
P/E Ratio44.19N/A-
Revenue178M1.03M17,215%
Total Cash291M26.3M1,106%
Total Debt41.1M31.2M132%
FUNDAMENTALS RATINGS
PLUR: Fundamental Ratings
PLUR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEPLUR
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
PLUR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FITGX22.03N/A
N/A
Fidelity Advisor International Growth M
PEICX22.96N/A
N/A
PGIM Jennison Value C
EGLIX10.06N/A
N/A
Eagle Energy Infrastructure I
PGLOX18.63N/A
N/A
T. Rowe Price Global Consumer
ACFGX85.84N/A
N/A
American Century Focused Dynamic Gr G